John Overdeck’s Sienna Biopharmaceuticals, Inc. SNNA Stock Holding History

John Overdeck’s Portfolio SNNA Stock Details SNNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-83,579	Closed	-$17K	–	4162
2019 Q3	$17K	Sell	83,579 -77,788	-48%	-$52.7K	﹤0.01%	3386
2019 Q2	$140K	Buy	161,367 +4,765	+3%	+$7.46K	﹤0.01%	3155
2019 Q1	$363K	Buy	156,602 +92,528	+144%	+$251K	﹤0.01%	2473
2018 Q4	$149K	Buy	+64,074	New	+$565K	﹤0.01%	2767

Other funds holding SNNA

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Private Ocean San Rafael, California $1.13B AUM 11.01% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

John Overdeck's SNNA Position: Q4 2019 in Review

John Overdeck sold out of Sienna Biopharmaceuticals, Inc. (SNNA) in Q4 2019, closing a stake of 83,579 shares — an estimated $17K sold.

John Overdeck first reported a position in SNNA in Q4 2018 and held it in 4 quarters. The position peaked at $363K in Q1 2019. 4 funds tracked by Wall St. Rank hold SNNA as of Q4 2019.

John Overdeck reported no remaining Sienna Biopharmaceuticals, Inc. position as of Q4 2019 after selling out during the quarter.
John Overdeck sold 83,579 Sienna Biopharmaceuticals, Inc. shares in Q4 2019, an estimated $17K.
John Overdeck first reported a position in Sienna Biopharmaceuticals, Inc. in Q4 2018 and held it in 4 quarters.
John Overdeck's Sienna Biopharmaceuticals, Inc. position peaked at $363K in Q1 2019.
4 funds tracked by Wall St. Rank held Sienna Biopharmaceuticals, Inc. as of Q4 2019.

Based on Two Sigma Investments's 13F filing for Q4 2019, filed 14 Feb 2020.